Annual Meeting on

Pharmacology

Melbourne, Australia   Oct 12-14, 2017

Melbourne, Australia Oct 12-14, 2017

Meetings International invites all the participants across the globe to attend ‘Annual Meeting on Pharmacology’ during September 04-06, 2017 in Paris, France which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology 2017 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs. 

Why to attend???

Join your peers around the world focused on learning about Pharmacology and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Pharmacology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are hallmarks of this conference. 

Target Audience: 

  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Universities
  • Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
  • Business Entrepreneurs, Training Institutes, Software developing companies
  • Manufacturing Medical Devices Companies, CRO and Data Management Companies.

 

Annual Meeting on Pharmacology

Melbourne, Australia   Oct 12-14, 2017

Pharmacology 2017 welcomes attendees, presenters, and exhibitors from all over the world to Paris, France. The event brings together truly innovative thinkers who are leading the way through current perspectives in drug research and development. We are delighted to invite you all to attend and register for the “9th World Congress on Pharmacology” (Pharmacology 2017) which is going to be held during September 04-06, 2017 at Paris, France. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Pharmacology 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Pharmacology 2017 organizing committee look forward to meeting you in Paris, France.

For more details please visit- http://www.meetingsint.com/pharma-conferences/pharmacology

Importance & Scope:

‘Pharmacology 2017’ is a perfect platform to present and discuss current perspectives in drug research and development. Pharmacology is the study of interaction of chemical with living systems. It is a medical science that forms a backbone of the medical profession. So, it’s important to describe the pharmacological basis of therapeutics in order to maximize the benefits and minimize the risks of drugs to recipients. It is an integrative rather than an autonomous science, drawing on the techniques and knowledge of many allied scientific disciplines. Hence it will be a platform for researchers, scientists, professional involved with drug development. It is with better understanding of Pharmacology one can know the right dosage of drugs. More research in pharmacology deals with identifying and responding to drug interactions reactions and side effects and treat accordingly. It is useful to understand the process of drug intake, absorption, distribution, metabolism and elimination. More intensive study with the interaction between drug and its effect helps in identify the properties of ideal drugs and otherwise. Branches of Pharmacology include:

  • Clinical pharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Cardiovascular pharmacology
  • Pharmacogenetics
  • Pharmacogenomics
  • Pharmacoepidemiology
  • Systems pharmacology
  • Toxicology
  • Theoretical pharmacology
  • Posology
  • Pharmacognosy

Major Pharmacology Associations around the Globe

·      American Academy of Veterinary Pharmacology and Therapeutics

·      American Board of Clinical Pharmacology

·      Argentine Society for Experimental Pharmacology

·      Association of Pharmacologists of Ukraine

·      Australian Physiological and Pharmacological Society

·      British Association for Psychopharmacology

·      Colombian Association of Pharmacology

Target Audience:

Students, Scientists, Researchers, and Faculty of Pharmaceutical Universities, Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies, Business Entrepreneurs, Training Institutes, Software developing companies, Manufacturing Medical Devices Companies, CRO and Data Management Companies. 

Global concentration of Research Organizations:

The graph represents the percentage of CROs. A significant portion of R&D budgets are spent on outsourcing services (domestic and/or international) offered by the CRO industry, approximately $15 billion in 2007.This figure is expected to grow at 15% over the next seven years and should increase further with the broadening of the spectrum of services outsourced to cover the entire value chain. As outsourced services in developing countries such as China and India move up the value chain to cover phase 1/2 trials, the total contracts value may increase to $30 billion by 2015.

Global concentration of Research Organizations:

The graph represents the percentage of CROs. A significant portion of R&D budgets are spent on outsourcing services (domestic and/or international) offered by the CRO industry, approximately $15 billion in 2007.This figure is expected to grow at 15% over the next seven years and should increase further with the broadening of the spectrum of services outsourced to cover the entire value chain. As outsourced services in developing countries such as China and India move up the value chain to cover phase 1/2 trials, the total contracts value may increase to $30 billion by 2015.

Glance at Market of Pharmacology:

These data describe the outcome of the patient as defined in U.S.reporting regulations. Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life threatening. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

Meetings International invites all the participants across the globe to attend 'Annual Meeting on Pharmacology' during October 12-14 in Melbourne, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology 2017 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

Track 1: Pharmacology

Pharmacology is the scientific study of drug action on biological systems. It is the study of the interactions between a living organism and drugs. If substances have medicinal properties, they are considered pharmaceuticals. Pharmacological studies range from the effects of chemical agents upon subcellular mechanisms, to those that deal with the potential hazards of pesticides and herbicides, to those that focus on the treatment of major diseases by drug therapy. It involves examining the interactions between chemical substances and living systems, with a view to determining the properties of drugs and drug actions, including the drug molecules and drug receptors interactions and how these interactions elicit an effect.

Track-2 Advances in Pharmacological Research

Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles are rising technologies for the rational delivery of chemotherapeutic drugs in the treatment various ailments. Nanoparticles present possible dangers, both medically and environmentally.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

Track-3 Toxicology and Pharmacology

The connected discipline of toxicology includes the study of the nature and mechanisms of deleterious effects of chemicals on living beings. The study of toxicology can be taken as system wise as well as agent wise. Toxicology deals with the interaction of chemicals with living systems. It is also the study of the science of numerous industries and regulatory agencies which are involved with the development and regulation of food additives to those involved with the use and remediation of hazardous chemicals. Toxicology has its impact on human life; it is primarily concerned with the identification of deleterious agents and for the removal of the toxins.

Pharmacology is the scientific study of drug action on biological systems. It is the study of the interactions between a living organism and drugs. If substances have medicinal properties, they are considered pharmaceuticals.

Track-4 Pharmacological Testing

Pharmacological tests are used to evaluate if a substance or plant extract is biologically active. There are many pharmacological tests and each test demonstrates various aspects that are important for the understanding of the mechanisms behind illnesses, their causes and cures. Many methods of pharmacological tests have been proposed for quantitative predictions in drug metabolism.

BCC Research report’s cover the latest pharmaceutical market and provide in-depth market analysis, forecasts, trends, patent analysis, and profiles of major players within the markets. Comprehensive analysis of clinical studies for biopharmaceuticals, prevention and treatment of certain cancers, coagulants and non-coagulants are all within the range of pharmaceutical markets. Drug devices, instrumentation and inhibitors are some of the many other areas covered.

Track-5 Clinical pharmacology and receptor theory

Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become especially important because of the association between drug application, microorganism abolition, and resistance.

Track-6 Food and Chemical Toxicology

Food and Chemical Toxicology (FCT), an internationally renowned journal, that publishes original research articles and reviews on toxic effects, in animals and humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs, and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products, and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques. Furthermore new areas such as safety evaluation of novel foods and biotechnologically derived products and inter-relationships between nutrition and toxicology are welcomed. The studies may address the physiological, biochemical or pathological changes induced by specific substances, techniques for assessing potential toxicity, including molecular biology or the mechanisms underlying toxic phenomena.

Track-7 Drug Screening and Discovery

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.

Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments.

Track-8 Environmental Pharmacology

Environmental pharmacology is a new and emerging specialty of pharmacology. It involves the study of gene-environment interaction, toxin-environment interaction and drug- environment interaction. Environmental pharmacology entails the study of environmental science, medicine, ecology, genetics and chemistry. The impact of pharmaceuticals on the ecosystem has significance public health implications. The demand for more pharmaceuticals relative to world’s population growth may place the public at risk though the destruction of species. The entry of chemicals and drugs into the aquatic ecosystem is of a serious concern and empirical evidences are making these concerns more compelling.

 

Track-9 Toxicology

Toxicology is the study of adverse effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.  It includes observing symptoms, mechanisms, detection and treatments of toxic substances, in relation to the poisoning of humans. It is the qualitative and quantitative study of the adverse effects of chemicals and other materials on living organisms. The dose of the substance is an important factor in toxicology, as it has a relationship with the effects on the individual. Factors that influence toxicity include the dose, the route of exposure, shape and structure of the chemical, the species, individual human factors and environment.

Track-10 Pharmacogenetics and Pharmacogenomics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers.

Track-11 Applied Pharmacology

Applied pharmacology is the study of how drugs affect body. Drugs can be used to both maintain a healthy lifestyle and treat or cure disease. Pharmacology deals with the basis, therapeutics uses of drugs, physiological action and  properties of action. Applied pharmacology helps to measure the data obtained from the clinical studies and can correlate it with the clinical processes. It also provides explanation for different drugs having connected with the pharmacological action. It gives clarifications about drug interactions and the action of various drugs on the many organs in the body when they are in diseased state with side effects contradictions. Applied pharmacology makes it possible not only to explain to the doctor the action of drugs in the human body, but also in evaluating the efficacy of drugs in a particular disease condition. 

Track-12 Cardiovascular Pharmacology

Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

Track-13 Pharmacokinetics and Pharmacodynamics

Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance.Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects.

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing.

Track-14 Neuropharmacology & Psychopharmacology

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. It is dealt with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

Track- 15 Nursing Pharmacology

Nursing Pharmacology  is the study of how guidlines for nurses with regard to the substances that interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are considered pharmaceuticals. It encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and antipathogenic capabilities.

Track-16 Biochemical Pharmacology

Biochemical pharmacology is based on principles of drug action. Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, subcellular compartments and individual protein molecules.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

Meetings International proudly announces the Global Experts Meeting on Pharmacology scheduled during October 12-14, 2017 at Melbourne, Australia

Meetings International provides a Global Platform for Pharma, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

The popularity of Formulation and Drug Delivery has increased significantly in recent years. The Drug Delivery Technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Drug delivery technology market offers a promising approach for the delivery of various kinds of drugs that have different molecular formulation. Drug delivery technology is aimed at maximizing the drug delivery at the targeted site so as to increase the efficiency of drug and proposing improved patient compliance.

Pharmacology Meeting will bring together key decision makers and innovators within this rapidly growing field. This intensive 3-Day program will examine various formulation and drug delivery strategies. The event will cover Pre-Formulation, Formulation Aspects, Pharmacokinetics and Pharmacodynamics, Drug Targeting, Drug Delivery Routes, Nano Drug Delivery Systems, Nanotechnology in Drug Delivery, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Applications of Biomaterials, Theranostics and Peptides and Protein Drug Delivery.

Additionally, the event will examine novel strategies for improving Vaccine Drug Delivery Systems, including stability and half-life will also be discussed along with novel routes of administration.  Case studies will be presented that illustrate the progress made in developing efficacious drug therapeutics, while leaders in the field point the way to the future for these promising drugs.

Join the industry’s leading drug development executives from numerous leading organizations to discuss and hear unique take-home examples, case studies and multiple drug development and delivery strategies to assist in reducing time-to-market on future drug products.

Attend to gain an unmatched experience.

Meetings International Pharmacology Meeting will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel drug development and commercialization strategies, which could speed up time to market and save your organization millions. We hope you will join us in Melbourne, Australia this July to enhance your drug delivery capabilities, and increase time to market on therapeutics.

Sincerely,

Operating Committee

CEO and Founder

Meetings International PTE LTD.

 

  • Pharmacology
  • Advances in Pharmacological Research
  • Toxicology and Pharmacology
  • Pharmacological Testing
  • Clinical pharmacology and receptor theory
  • Food and Chemical Toxicology
  • Drug Screening and Discovery
  • Environmental Pharmacology
  • Toxicology
  • Pharmacogenetics and Pharmacogenomics
  • Applied Pharmacology
  • Cardiovascular Pharmacology
  • Pharmacokinetics and Pharmacodynamics
  • Neuropharmacology & Psychopharmacology
  • Nursing Pharmacology
  • Biochemical Pharmacology